KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

Reza Abdi, MD Appointed Director of Transplant Nephrology and Kidney Transplant Immunobiology, UCLA Kidney Transplant Immunobiology Program

The UCLA Department of Medicine is pleased to announce the establishment of the Kidney Transplant Immunobiology Program (KTIP) in the David Geffen School of Medicine[...]

Kidney Nutrition for Value-Based Care Models: The Role of Low Protein Diets and Keto-Analogue Supplementation to Delay Dialysis

Saville J, Moore LW, Narasaki Y, Kalantar-Zadeh K. Kidney Nutrition for Value-Based Care Models: The Role of Low Protein Diets and Keto-Analogue Supplementation to Delay[...]

NAD Metabolism Regulates Proliferation of Macrophages in Atherosclerosis

Sinha S, Swichkow CR, Farahi L, Péterfy M, Pan C, Zhou Z, Seldin M, Mack JJ, Davis RC, Shih D, Lusis AJ. NAD Metabolism Regulates[...]